Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neoplasm Metastasis × famitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Triple Negative Breast Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Solid Tumor 2 Small Cell Lung Carcinoma 2 Ovarian Neoplasms 2 Gastrointestinal Stromal Tumors 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Thyroid Neoplasms 1 Recurrence 1 Non-squamous Non-small-cell Lung Cancer 1 Non Squamous Non Small Cell Lung 1 Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Melanoma 1 Gastro-enteropancreatic neuroendocrine tumor 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Neoplasms 1 Disease Progression 1 Cholangiocarcinoma 1 Cervical Cancer Metastatic 1 Carcinoma, Transitional Cell 1 BRCA-Mutated Breast Carcinoma 1 Advanced Solid Tumor 1 Advanced NSCLC 1

Interventions

pembrolizumab 134 Gemcitabine 122 Capecitabine 113 Fluorouracil 106 Paclitaxel 105 Oxaliplatin 96 Bevacizumab 95 Nivolumab 90 Leucovorin 89 Docetaxel 80 Radiosurgery 78 Irinotecan 78 Cisplatin 75 Carboplatin 74 Magnetic Resonance Spectroscopy 65 Cyclophosphamide 62 Cetuximab 60 Biopsy 54 Specimen Handling 52 Trastuzumab 50 Radiotherapy 48 Ipilimumab 44 Everolimus 41 Drug Therapy 40 Pemetrexed 39 Albumin-Bound Paclitaxel 39 130-nm albumin-bound paclitaxel 38 Doxorubicin 36 aldesleukin 35 Fulvestrant 34

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04355858 2022-07-26

MULAN

Fudan University

Phase 2 Unknown

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡